Drug development service company
Total Trials
1
As Lead Sponsor
0
As Collaborator
Total Enrollment
150
NCT04436848
LRRK2 G2385R Leucocyte and Urine Biomarker Study
Phase: N/A
Role: Collaborator
Start: Jun 1, 2020
Completion: Jun 30, 2022
Loading map...